A lthough hypertension can result from multiple pathophysiologic conditions, 1 hemodynamic derangements of elevated cardiac output, systemic vascular resistance, or both are the phenotypic characteristics of increased blood pressure (BP). Subjects who are younger or pregnant are more likely to have a high cardiac output as a component of their hypertension. 2, 3 In contrast, increased systemic vascular resistance often associated with either normal or reduced cardiac output is the hallmark of hypertensive stages in older subjects. 4 However, significant heterogeneity in cardiac output and systemic vascular resistance exists across all age groups. The characterization of the specific hemodynamic components of hypertension has implications in the choice of antihypertensive therapy. Reductions in BP are obtained by use of antihypertensive medications that alter cardiac output, fluid volume, or systemic vascular resistance. 5, 6 Despite the multitude of pharmacologic options that are available today, a suboptimal medical regimen is a leading cause of failure to control BP.
Recently, impedance cardiography (ICG) has gained popularity as a noninvasive method to measure hemodynamic variables in hypertensive patients. 8 -11 The technology of ICG involves the measurement of thoracic impedance through the placement of four dual sensors on the neck and chest. Changes in electrical impedance are digitally processed and used to calculate parameters of blood flow (cardiac output [CO] , cardiac index [CI] , stroke volume [SV] , and stroke index [SI] ), vascular resistance (systemic vascular resistance [SVR] , systemic vascular resistance index [SVRI]), and chest fluid level (thoracic fluid content [TFC] ). Physiologically, arterial compliance is known to express the relationship between stroke volume and pulse pressure. 12, 13 Therefore, a patient's arterial compliance (total arterial compliance index [TACI] ) can be easily measured by dividing ICG stroke index by the pulse pressure calculated from the patient's systolic BP (SBP) and diastolic BP (DBP). 13, 14 The ability of ICG to provide accurate and reproducible measures of hemodynamic parameters that correlate well with invasive hemodynamic measures has been demonstrated in a wide variety of patients with cardiovascular disease. [15] [16] [17] [18] [19] The use of ICG allows identification of the underlying hemodynamic abnormalities in patients with hypertension 20 -22 and also in discerning risk that is not apparent from measurements of BP levels alone. 4, 22 The use of ICG has been shown to aid therapeutic decision making and to improve BP control. 23, 24 Population studies have shown that the risk of cardiovascular morbidity and mortality increases steadily with increasing levels of BP, beginning at levels as low as 115/75 mm Hg. 25 In recognition of the significance of even minor elevations of BP, the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC-7) 26 elected to define a new BP category called prehypertension. This is characterized as SBP between 120 and 139 mm Hg or DBP between 80 and 89 mm Hg. In addition, JNC-7 combined previously defined stages 2 and 3 hypertension into a single category, stage 2, defined as BP Ն160/100 mm Hg. 26 The goal of this study was to use ICG to characterize the hemodynamic characteristics of the various stages of hypertension to gain insight into whether variations in cardiac output, vascular resistance, or both may provide additional information in tailoring therapies.
Methods

Patients
The sample of subjects retrospectively reviewed in this study included hypertensive patients who presented for consultation at an academic tertiary care clinic and healthy normal subjects Ͻ30 years of age without known established disease. The study was approved by the institutional review board, and all patients signed a consent form before inclusion in the study.
Data Collection
Demographic and medication information was recorded for each subject. Hypertension was defined as active treatment with any antihypertensive agent or current SBP Ն140 mm Hg or DBP Ն90 mm Hg. Vascular disease was identified through patient history and was defined by clinical diagnosis of peripheral artery disease, antecedent evidence of a previous stroke, or carotid disease. Blood pressure was taken with the patient seated using the oscillometric method. Hemodynamic measurements were performed using the BioZ ICG Monitor (CardioDynamics, San Diego, CA) by a technician after 5 min of rest in the supine position; these included heart rate, CI, SI, SVRI, TACI, and TFC. In this study, the index values were chosen to help normalize the results by body surface area. The exact calculation of these parameters has been described. 27 Hemodynamic data were transcribed from the printed ICG report to a Microsoft Excel spreadsheet (Microsoft Corp., Redmond, WA) by a research technician. Total arterial compliance index was calculated as stroke index divided by pulse pressure and expressed in units of mL/m 2 mm Hg.
13,14
Categorization of BP 
Statistical Analysis
Data analysis was performed by an independent statistician using the Statistical Analysis Software program (SAS Institute, Cary, NC). Discreet variables such as gender, race, BP category, and medications were summarized as N (%). Continuous variables were summarized as mean Ϯ SD. Differences in ICG hemodynamic parameters among BP categories were examined for differences using the Student t test. The relationships of demographic and baseline variables to ICG hemodynamic parameters were evaluated by linear regression modeling.
Results
Patients
A total of 155 subjects were evaluated, including 19 subjects with BP Ͻ140/90 mm Hg and 136 subjects with established hypertension. Demographic, BP, and medica-
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tion data for all study subjects are shown in 
Hemodynamic Characterization
Hemodynamic parameters for nonhypertensive subjects are shown in Table 2 . Prehypertensive subjects had significantly higher SBP (124 v 110 mm Hg, P Ͻ .001) and pulse pressure (51.2 v 40.9 mm Hg, P Ͻ .01) and lower TACI (0.97 v 1.21 mm Hg/mL/m 2 , P Ͻ .05) than those without prehypertensive BP levels. Heart rate and CI trended to be higher and stroke index trended to be lower in the prehypertensive group, but these differences did not reach statistical significance (P ϭ .20 and 0.13, respectively).
Hemodynamic parameters for hypertensive subjects are shown in Table 3 . Compared with all nonhypertensive subjects, patients with stage 1 and stage 2 hypertension had significantly lower stroke index (35 v Scatter plots comparing SBP with SVRI, TACI, and CI in all study subjects is shown in Figs. 1, 2 , and 3, respectively. Total arterial compliance index had a strong negative correlation with SBP (R ϭ Ϫ0.75, P Ͻ .0001), and SVRI had a lower positive correlation (R ϭ 0.62, P Ͻ .0001). Cardiac index had a low negative correlation with SBP (R ϭ Ϫ0.30, P Ͻ .001); however, when evaluated solely in nonhypertensive subjects, CI and SBP trended to be positively correlated (R ϭ 0.44, P Ͼ .05).
Although there was a modest and statistically significant correlation between SVRI and SBP, a significant variation was observed at various SBP levels, as illustrated in Table 4 . The normal range for SVRI is 1337 to 2483 dyne ⅐ sec ⅐ cm Ϫ5 ⅐ m 2 . 28 A total of 22.2% of subjects with BP Ͻ120/80 mm Hg and 50.0% of subjects with SBP between 120 and 139 mm Hg and DBP between 80 and 89 mm Hg showed vasoconstriction, as evidenced by high SVRI values. In subjects with BP Ͼ140/90 mm Hg, 8.9% of subjects had SVRI in the normal range.
Correlations of various hemodynamic parameters and demographic variables are shown in Table 5 . The highest correlations were found between TACI and age (R ϭ Ϫ0.54, P Ͻ .0001) and TFC with male gender (R ϭ 0.48, P Ͻ .0001). The number of antihypertensive medications had a negative association with CI (R ϭ Ϫ0.34, P Ͻ .0001) and TACI (R ϭ Ϫ0.44, P Ͻ .0001) and a positive association with SVRI (R ϭ 0.40, P Ͻ .0001).
Discussion
Characterization of hemodynamic correlates of hypertension by a noninvasive method documents the nonhomogeneous nature of the mechanisms that contribute to the elevation in arterial pressure and underscores important differences between nonhypertensive and hypertensive subjects. Moreover, our findings document for the first time significant differences between ICG hemodynamic parameters in subjects with controlled versus uncontrolled hypertension and in subjects with controlled hypertension versus normotension. Subjects with prehypertension had a higher TACI than those with BP Ͻ120/80 mm Hg, a finding that substantiates the 
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risk for progression of vascular disease in this group of individuals. In this study, we chose to use the indexed values of the more commonly referenced variables of cardiac output, systemic vascular resistance, and total arterial compliance by normalizing each of these to body surface area. The effects of gender and body mass index in determining parameter differences may be minimized. This approach may also allow the results to be generalized to populations with different gender and body mass index values, although this possibility will require additional studies in a larger population of subjects.
An important observation derived from determinations of ICG hemodynamic variables across BP levels appears to be those of SVRI and TACI. A higher BP was associated with higher SVRI and lower TACI in both controlled and uncontrolled hypertension and stage 1 and stage 2 hypertension. These results are in alignment with the known pathophysiology of hypertension, which initially results from decreased arterial compliance and is often followed by an associated increased systemic vascular resistance. 29 Systemic vascular resistance index was not different in prehypertensive normal subjects and those with controlled BP Ͻ120/80 mm Hg. The observation that total vascular resistance index did not reach normal values in subjects with SBP between 120 and 140 mm Hg is another important finding in this study, as it substantiates the possibility that the choice of medication used in these subjects may be an important element in guiding therapeutic decisions. 30 The transition from the normal state to the hypertensive state is heterogeneous and may be bimodal among individuals with prehypertension-a group in which some individuals have elevated cardiac output with low-to-normal systemic vascular resistance, whereas others have elevated vascular resistance with low or normal cardiac output.
Higher arterial stiffness has proved to be a BPindependent predictor of cardiovascular morbidity and mortality. [31] [32] [33] [34] [35] [36] In this study, a reduced TACI was associated with increasing age, a finding that is consistent with known age-related changes in arterial elastic tissue. Despite an age-related association, TACI readily separated not only hypertensive subjects from the normal group but also differentiated truly normal subjects from those with prehypertension. The validity of the TACI will need to be correlated with the anatomical changes of small resistance arteries in future studies. This parameter could then prove to be of great significance in the clinical evaluation of hypertensive patients.
Within the nonhypertensive subjects, CI trended higher as BP increased, as has been shown previously, 2 although the numbers were small and the correlation was not strong. Cardiac index was significantly lower in the hypertensive subjects than in the normal subjects, a known effect of aging that is caused by decreased aortic and vascular compliance, decreased myocardial contractility, increased systemic vascular resistance, and decreased intravascular volume. 37, 38 The TFC was also significantly different between hypertensive and nonhypertensive individuals, although it did not differ according to different BP levels in both groups. Paradoxically, TFC was lower in the hypertensive patients than in the normotensive subjects. These data may be interpreted to suggest that thoracic fluid volume was controlled to a greater degree in the hypertensive patients, possibly by diuretics and salt restriction. In previous studies, TFC has been shown to accurately reflect changes in extravascular and intravascular volume changes. 39, 40 In this study, higher values were correlated with male gender (Table 5) , consistent with the published normal ranges for the parameter of 30 to 50/kOhm for men and 21 to 37/ kOhm for women. 30 Evidence of decreased intravascular volume in older subjects may also be supported by the significantly lower TFC in the hypertensive subjects, who were significantly older but who had similar body surface area values.
The significant differences in hemodynamic parameters 
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across the different BP levels illustrate the progression of hemodynamic characteristics with the severity of hypertension. However, it is important to note the significant inter-subject variation in hemodynamic parameters that exists within a BP category. There can be significant individual patient variation when SBP is compared with SVRI, CI, or TACI. In the clinic, there is a limited ability to determine vascular resistance using measurement of BP alone. At all levels of BP, vascular resistance may be high or normal.
Various investigators have evaluated the ability of physicians to accurately estimate cardiac output and vascular resistance from clinical examination alone in critically ill patients. The accuracy of predicting the underlying hemodynamic parameters by clinical evaluation alone is low. 39 -41 In patients with hypertension, it may be even less likely that physical examination can reveal hemodynamic status than in more severely ill patients who present with symptomatic heart disease. This analysis shows that various demographic factors and the number of medications used have a modest correlation with underlying hemodynamic parameters. It therefore appears that there is no substitute for direct measurement of hemodynamic parameters, as clinicians are not likely to reliably estimate specific hemodynamic values in an individual hypertensive patient from the physical examination or other clinically readily available factors.
It is tempting to suggest that our findings provide some insight into the relatively low levels of BP control in patients with hypertension. As estimated by data from the National Heart, Lung, and Blood Institute, only 34% of hypertensive adults Ͻ75 years of age have their hypertension controlled at the level of 140/90 mm Hg. In addition, hypertension management is even less successful for the elderly population. 26 Because precise measures of hemodynamic variables are outside the scope of the clinical office work-up, the choice of antihypertensive therapy is more often empirical and less likely to target and monitor the hemodynamic abnormalities for the particular patient. The ICG method was used in a randomized controlled trial to identify the initial and ongoing hemodynamic parameters of patients with resistant hypertension. The efficacy of antihypertensive therapy was improved by 70% in that study.
11
Because the success of antihypertensive therapy may be improved when medications target the appropriate hemodynamic characteristic, the findings of this study may provide support for future studies linking the use of ICG-guided therapy to improvement in BP control.
This study was limited by the inclusion of a selected patient population comprised of those referred to an academic, tertiary hypertension clinic. Patients were receiving therapy at the time of their evaluation, and medications were not stopped before hemodynamic assessment. Thus, hemodynamic parameters may reflect not only the underlying hemodynamic derangements associated with the hypertension but may also be influenced to varying degrees by the choice and intensity of antihypertensive medications. Although antihypertensive medication classes were recorded, the specific agent and dose were not, thereby preventing a medication analysis. In addition, there were a limited number of truly normal subjects, which limited the statistical power to determine differences within that group. The normal group consisted of subjects who were significantly younger than the hypertensive subjects. Finally, this study did not perform serial hemodynamic assessments and therefore did not assess the ability of the various ICG variables to characterize changes over time due to disease progression or therapy.
In conclusion, the categories of BP defined by JNC-7 are characterized by significantly different hemodynamic values, but significant variation in hemodynamic values among BP categories exists. Hemodynamic findings in an individual patient cannot be predicted by BP values, demographic information, or medications. Noninvasive ICG can help to characterize hemodynamic values and to identify variance at similar BP levels, which may improve BP management. 
